Basingstoke Surgical Technology Limited 03018316 false 2025-03-01 2026-02-28 2026-02-28 The principal activity of the company is Medical supply sales Digita Accounts Production Advanced 6.30.9574.0 true 03018316 2025-03-01 2026-02-28 03018316 2026-02-28 03018316 core:CurrentFinancialInstruments core:WithinOneYear 2026-02-28 03018316 bus:Micro-entities 2025-03-01 2026-02-28 03018316 bus:AuditExemptWithAccountantsReport 2025-03-01 2026-02-28 03018316 bus:FilletedAccounts 2025-03-01 2026-02-28 03018316 bus:SmallCompaniesRegimeForAccounts 2025-03-01 2026-02-28 03018316 bus:RegisteredOffice 2025-03-01 2026-02-28 03018316 bus:Director1 2025-03-01 2026-02-28 03018316 bus:PrivateLimitedCompanyLtd 2025-03-01 2026-02-28 03018316 countries:EnglandWales 2025-03-01 2026-02-28 03018316 2024-03-01 2025-02-28 03018316 2025-02-28 03018316 core:CurrentFinancialInstruments core:WithinOneYear 2025-02-28 iso4217:GBP xbrli:pure

Registration number: 03018316

Basingstoke Surgical Technology Limited

Unaudited Filleted Financial Statements

for the Year Ended 28 February 2026

 

Basingstoke Surgical Technology Limited

(Registration number: 03018316)
Balance Sheet as at 28 February 2026

2026
£

2025
£

Fixed assets

1,627

2,170

Current assets

4,377

11,576

Creditors: Amounts falling due within one year

(3,481)

(3,883)

Net current assets

896

7,693

Total assets less current liabilities

2,523

9,863

Accruals and deferred income

(682)

(645)

 

1,841

9,218

Capital and reserves

1,841

9,218

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
c/o Rumford & Co
10 West Lodge Avenue
London
W3 9SF

These financial statements were authorised for issue by the director on 15 June 2026.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 0 (2025 - 0).

For the financial year ending 28 February 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

 

Basingstoke Surgical Technology Limited

(Registration number: 03018316)
Balance Sheet as at 28 February 2026

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 15 June 2026
 

.........................................
Mr Richard John Heald
Director